Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25. In the deal valued at $0.92 per share,15,600 shares were bought. As a result of this transaction, BUNKA CHRISTOPHER now holds 270,012 shares worth roughly $0.22 million.
Then, BUNKA CHRISTOPHER bought 11,900 shares, generating $10,866 in total proceeds. Upon buying the shares at $0.91, the Director now owns 281,912 shares.
Before that, McKechnie William Edward bought 5,000 shares. Lexaria Bioscience Corp shares valued at $4,532 were divested by the Director at a price of $0.91 per share. As a result of the transaction, McKechnie William Edward now holds 18,191 shares, worth roughly $15098.529999999999.
Price Performance Review of LEXX
On Tuesday, Lexaria Bioscience Corp [NASDAQ:LEXX] saw its stock jump 1.46% to $0.83. Over the last five days, the stock has lost -5.28%. Lexaria Bioscience Corp shares have fallen nearly -76.78% since the year began. Nevertheless, the stocks have fallen -60.31% over the past one year. While a 52-week high of $4.38 was reached on 01/06/25, a 52-week low of $0.78 was recorded on 08/11/25.
Levels Of Support And Resistance For LEXX Stock
The 24-hour chart illustrates a support level at 0.8077, which if violated will result in even more drops to 0.7818. On the upside, there is a resistance level at 0.8547. A further resistance level may holdings at 0.8758.
How much short interest is there in Lexaria Bioscience Corp?
A steep rise in short interest was recorded in Lexaria Bioscience Corp stocks on 2025-07-31, dropping by -0.2 million shares to a total of 0.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 0.52 million shares. There was a decline of -65.0%, which implies that there is a negative sentiment for the stock.
